Biochemical analyses reveal new insights into RCAN1/Rcn1 inhibition of calcineurin

• Published in: The FEBS journal 2024-11, Vol.291 (21), p.4813-4829
• Main Authors: Ren, Yan, Chen, Hui, Zhao, Shan‐Yue, Ma, Lei, He, Qing‐Xia, Gong, Wei‐Bin, Wu, Jia‐Wei, Yao, Hong‐Wei, Wang, Zhi‐Xin
• Format: Article
• Language: English
• Subjects: Biochemistry; calcineurin; Calcineurin - chemistry; Calcineurin - genetics; Calcineurin - metabolism; Calcineurin Inhibitors - pharmacology; Calcium-Binding Proteins - chemistry; Calcium-Binding Proteins - genetics; Calcium-Binding Proteins - metabolism; calmodulin; Catalytic activity; Catalytic Domain; DNA-Binding Proteins - chemistry; DNA-Binding Proteins - genetics; DNA-Binding Proteins - metabolism; Humans; In vivo methods and tests; Intracellular Signaling Peptides and Proteins - chemistry; Intracellular Signaling Peptides and Proteins - genetics; Intracellular Signaling Peptides and Proteins - metabolism; Kinetics; Muscle Proteins - chemistry; Muscle Proteins - genetics; Muscle Proteins - metabolism; NFAT; noncompetitive inhibition; Phosphatase; Phosphoric Monoester Hydrolases; Protein Binding; Saccharomyces cerevisiae - enzymology; Saccharomyces cerevisiae - genetics; Saccharomyces cerevisiae - metabolism; Saccharomyces cerevisiae Proteins - antagonists & inhibitors; Saccharomyces cerevisiae Proteins - chemistry; Saccharomyces cerevisiae Proteins - genetics; Saccharomyces cerevisiae Proteins - metabolism; Substrate inhibition; Yeast; Yeasts
• ISSN: 1742-464X; 1742-4658; 1742-4658
• DOI: 10.1111/febs.17266

Calcineurin is a serine/threonine protein phosphatase that is highly conserved from yeast to human and plays a critical role in many physiological processes. Regulators of calcineurin (RCANs) are a family of endogenous calcineurin regulators, which are capable of inhibiting the catalytic activity of calcineurin in vivo and in vitro. In this study, we first characterized the biochemical properties of yeast calcineurin and its endogenous regulator Rcn1, a yeast homolog of RCAN1. Our data show that Rcn1 inhibits yeast calcineurin toward pNPP substrate with a noncompetitive mode; and Rcn1 binds cooperatively to yeast calcineurin through multiple low‐affinity interactions at several docking regions. Next, we reinvestigated the mechanism underlying the inhibition of mammalian calcineurin by RCAN1 using a combination of biochemical, biophysical, and computational methods. In contrast to previous observations, RCAN1 noncompetitively inhibits calcineurin phosphatase activity toward both pNPP and phospho‐RII peptide substrates by targeting the enzyme active site in part. Re‐analysis of previously reported kinetic data reveals that the RCAN1 concentrations used were too low to distinguish between the inhibition mechanisms [Chan B et al. (2005) Proc Natl Acad Sci USA 102, 13075]. The results presented in this study provide new insights into the interaction between calcineurin and RCAN1/Rcn1. Regulators of calcineurin (RCANs) are a family of endogenous calcineurin phosphatase inhibitors that have been linked to many diseases such as Down syndrome and Alzheimer's disease. Here, we characterized the inhibitory mechanism of the RCAN family through investigating enzyme kinetics, NMR titrations, and AlphaFold2 modeling. Our findings revealed that RCANs interact with calcineurin at multiple regions and noncompetitively inhibit calcineurin activity by targeting its active site in part, distinct from the self‐inhibition exerted by the autoinhibitory domain.